Cancer News and Research

Latest Cancer News and Research

Male hormone testosterone may increase risk of colon cancer

Previous cancer research has revealed that women are less likely than men to suffer from non-sex specific cancers such as cancer of the colon, pancreas and stomach. Scientists theorized that perhaps this trend was due to a protecting effect created by female hormones, such as estrogen, that help prevent tumors from forming. Now, researchers at the University of Missouri have found evidence suggesting that the male hormone testosterone may actually be a contributing factor in the formation of colon cancer tumors.

11 Dec 2014

New technique allows rapid, large-scale studies of gene function

Using a gene-editing system originally developed to delete specific genes, MIT researchers have now shown that they can reliably turn on any gene of their choosing in living cells.

11 Dec 2014

Added benefit of daclatasvir drug not proven for chronic hepatitis C infection

The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.

11 Dec 2014

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.

11 Dec 2014

Silvia Jurisson recognized as AAAS Fellow for contributions to cancer research

Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.

11 Dec 2014

$Using Refractory Metals in Cancer Treatments$

Using Refractory Metals in Cancer Treatments

This interview discusses how refractory metals can be used in cancer treatments.

From H.C. Starck Solutions 10 Dec 2014

Carboplatin and paclitaxel show promise for advanced thymic carcinoma

A multicentre, phase II study of carboplatin and paclitaxel in chemotherapy-naïve patients with advanced thymic carcinoma has shown that the treatment has promising efficacy compared with standard anthracycline-based chemotherapy.

10 Dec 2014

PD-L1 expression tied to favourable prognosis in SCLC

Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.

10 Dec 2014

UTHealth opens Trauma and Grief Center for Youth

Children who are having difficulty processing trauma or loss can now turn to the Trauma and Grief Center for Youth at The University of Texas Health Science Center at Houston.

10 Dec 2014

Cancer Council urges partners of men diagnosed with prostate cancer to reach out for support

Cancer Council is calling on partners of men with prostate cancer to reach out for support, with research showing partners experience high levels of distress related to the diagnosis of their loved one.

10 Dec 2014

Myriad Genetics highlights three new studies at SABCS 2014

Myriad Genetics, Inc. today announced results from a new study that demonstrated the ability of the myRisk Hereditary Cancer test to detect 105 percent more mutations in cancer causing genes than conventional BRCA testing alone. The Company also presented two key studies in triple negative breast cancer (TNBC) that show the myChoice HRD test accurately predicted response to platinum-based therapy in patients with early-stage TNBC and that the BRACAnalysis molecular diagnostic test significantly predicted response to platinum-based drugs in patients with metastatic TNBC.

10 Dec 2014

Variations in ERAP1 enzyme could lead to Ankylosing Spondylitis

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

10 Dec 2014

Genetic variations may contribute to treatment-related cognitive problems in children with ALL

Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL), according to a study led by researchers from Boston Children's Hospital, The Children's Hospital at Montefiore, and Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

10 Dec 2014

Use of HF-WBI for patients with early-stage breast cancer increases 17.4%, study finds

The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live ≥50 miles away from a cancer center, according to a study published in the December 1, 2014 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology.

10 Dec 2014

E-cigarettes not as addictive as tobacco cigarettes

E-cigarettes appear to be less addictive than cigarettes in former smokers and this could help improve understanding of how various nicotine delivery devices lead to dependence, according to researchers.

10 Dec 2014

University of Chicago Medicine takes steps to increase age limit of pediatric trauma program

The University of Chicago Medicine is taking formal steps to raise the age limit of its pediatric trauma program by two years to include 16- and 17-year-old children.

10 Dec 2014

Heat-shock protein 90 enables ER+ breast cancers to develop resistance to hormonal therapy

Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 (HSP90) also enables estrogen receptor-positive (ER+) breast cancers to develop resistance to hormonal therapy.

10 Dec 2014

Revolutionary new approach uses advanced technology to remove head and neck cancer tumors

In a groundbreaking new study, UCLA researchers have for the first time advanced a surgical technique performed with the help of a robot to successfully access a previously-unreachable area of the head and neck.

10 Dec 2014

Report supports potential of focused ultrasound to treat certain OCD patients

A recently published report in the Journal of Molecular Psychiatry supports the potential of focused ultrasound to treat certain patients with obsessive-compulsive disorder (OCD).

10 Dec 2014

McGill University scientists show how simple potato extract can fight obesity

Take a look in your pantry: the miracle ingredient for fighting obesity may already be there. A simple potato extract may limit weight gain from a diet that is high in fat and refined carbohydrates, according to scientists at McGill University. The results of their recent study were so surprising that the investigators repeated the experiment just to be sure.

10 Dec 2014

Cancer News and Research

Latest Cancer News and Research

Male hormone testosterone may increase risk of colon cancer

New technique allows rapid, large-scale studies of gene function

Added benefit of daclatasvir drug not proven for chronic hepatitis C infection

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

Silvia Jurisson recognized as AAAS Fellow for contributions to cancer research

Using Refractory Metals in Cancer Treatments

Carboplatin and paclitaxel show promise for advanced thymic carcinoma

PD-L1 expression tied to favourable prognosis in SCLC

UTHealth opens Trauma and Grief Center for Youth

Cancer Council urges partners of men diagnosed with prostate cancer to reach out for support

Myriad Genetics highlights three new studies at SABCS 2014

Variations in ERAP1 enzyme could lead to Ankylosing Spondylitis

Genetic variations may contribute to treatment-related cognitive problems in children with ALL

Use of HF-WBI for patients with early-stage breast cancer increases 17.4%, study finds

E-cigarettes not as addictive as tobacco cigarettes

University of Chicago Medicine takes steps to increase age limit of pediatric trauma program

Heat-shock protein 90 enables ER+ breast cancers to develop resistance to hormonal therapy

Revolutionary new approach uses advanced technology to remove head and neck cancer tumors

Report supports potential of focused ultrasound to treat certain OCD patients

McGill University scientists show how simple potato extract can fight obesity

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in